| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/24/2005 | CN1657048A Laminaran granule and its preparation technology |
| 08/24/2005 | CN1657044A Chlorretadin oral disintegrating tablet and its preparation method |
| 08/24/2005 | CN1657043A Formula of lianbizhi preparation and its preparation method |
| 08/24/2005 | CN1216053C 2,2-disubstituted 1,3-dioxolanes as antitussive atents |
| 08/24/2005 | CN1215879C 人类sars冠状病毒受体抑制剂 Human sars coronavirus receptor inhibitors |
| 08/24/2005 | CN1215874C Medicine for resolving sputum and relieving asthma and cough, preparing process thereof |
| 08/24/2005 | CN1215861C Xiasangju effervescent tablet and its preparing process |
| 08/24/2005 | CN1215832C 气雾剂组合物 Aerosol composition |
| 08/23/2005 | US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles |
| 08/23/2005 | US6933314 Integrin receptor inhibitors |
| 08/23/2005 | US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock |
| 08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 08/23/2005 | US6933305 Amide compounds and use thereof |
| 08/23/2005 | US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders |
| 08/23/2005 | US6933295 Substituted isoindoles and the use thereof |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932965 Separation of deamidated and non-deamidated human dnases and use of the non-deamidated species as a pharmaceutical per se; administering to patients suffering from pulmonary distress |
| 08/18/2005 | WO2005074955A1 Preparations containing echinacea extracts and thiocyanate |
| 08/18/2005 | WO2005074907A1 Gene expression controlling agent |
| 08/18/2005 | WO2003072601A8 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/18/2005 | US20050182128 For preventing or reducing dysplastic lesions |
| 08/18/2005 | US20050182103 Substituted 2,3-diphenyl pyridines |
| 08/18/2005 | US20050182101 Prodrugs of proton pump inhibitors |
| 08/18/2005 | US20050182100 Method of use |
| 08/18/2005 | US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 08/18/2005 | US20050182093 Novel compounds |
| 08/18/2005 | US20050182070 Method for the treatment of allergic conditions |
| 08/18/2005 | US20050182069 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents; 2[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetamide |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia |
| 08/18/2005 | US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050181501 Anti-TECK antibodies and methods of use therefor |
| 08/18/2005 | US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders |
| 08/18/2005 | US20050181357 Nucleotide sequences comprisied of spike and nucleocapsid coding sequence for use as amplification tool in detection of coronaviral infection |
| 08/18/2005 | US20050181066 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency |
| 08/18/2005 | US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 08/18/2005 | US20050181031 Permeation enhancer comprising fatty acid ester and/or a terpene; urogenital and respiratory system disorders |
| 08/18/2005 | US20050180925 Formulations and methods for treating rhinosinusitis |
| 08/18/2005 | CA2554927A1 Stable amorphous forms of montelukast sodium |
| 08/18/2005 | CA2554572A1 Montelukast free acid polymorphs |
| 08/18/2005 | CA2552938A1 Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
| 08/18/2005 | CA2552928A1 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 08/18/2005 | CA2552458A1 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| 08/18/2005 | CA2551780A1 The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
| 08/18/2005 | CA2550848A1 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 08/17/2005 | EP1563845A1 Remedies for allergic diseases |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1562949A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 08/17/2005 | EP1562903A2 Mucin synthesis inhibitors |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP1562603A2 Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 08/17/2005 | EP1562599A1 Quaternary ammonium compounds as muscarinic receptor antagonists |
| 08/17/2005 | EP1562584A1 Novel hydroxyindoles, use as inhibitors of phosphodiesterase 4 and method for production thereof |
| 08/17/2005 | EP1562579A1 Therapeutic delivery of carbon monoxide |
| 08/17/2005 | EP1562568A1 Treatment of heaves |
| 08/17/2005 | EP1562563A2 Methods for treatment of thiol-containing compound deficient conditions |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1315496B1 The treatment of inflammatory disorders |
| 08/17/2005 | EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 08/17/2005 | EP1280757B1 New gamma selective retinoids |
| 08/17/2005 | EP1225913B1 Use of nitric oxide for the treatment of airway constriction |
| 08/17/2005 | EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP1144385B1 Benzoheterocycles and their use as mek inhibitors |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | EP0835128B1 Use of il-11 to treat inflammation |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 08/17/2005 | CN1656098A Fused bicyclic pyrimidine derivatives |
| 08/17/2005 | CN1656097A Xanthine phosphodiesterase V inhibitor polymorphs |
| 08/17/2005 | CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
| 08/17/2005 | CN1656092A Robertson Graeme Michael et al. |
| 08/17/2005 | CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 08/17/2005 | CN1656082A Protein kinase inhibitors |
| 08/17/2005 | CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1656070A Melanocortin receptor ligands |
| 08/17/2005 | CN1656067A New salts |
| 08/17/2005 | CN1655846A Combination of a PDE inhibitor and a leukotriene receptor antagonist |
| 08/17/2005 | CN1655823A Topically applicable pharmaceutical preparation |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655808A Compositions for treating and/or preventing pollinosis |
| 08/17/2005 | CN1655799A Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 08/17/2005 | CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 08/17/2005 | CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 08/17/2005 | CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1655770A Chewable soft capsule |
| 08/17/2005 | CN1655766A Sustained release of guaifenesin combination drugs |
| 08/17/2005 | CN1655765A Sustained release pharmaceutical preparations and methods for producing the same |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |